US FDA Warns Foreign Manufacturers Of OTC Analgesics For Monograph Non-Compliance
Malaysia-based Furley Bioextracts and Honduras-based Laboratorio Pharma International receive warning letters from the US FDA following import alerts in May and June for marketing products as OTC analgesic drugs without complying with controlling monograph conditions.
You may also be interested in...
Adventure Ready Brands is the second small firm warned recently by FDA about manufacturing and marketing products labeled as nonprescription drugs but noncompliant with relevant OTC drug monographs and about GMP violations.
Eosera has removed its Ear Pain MD and Ear Itch MD products from e-commerce pages on its website following FDA's warning letter. The warning identifying the pain and itch products as unapproved new drugs also states that a January inspection of the firm’s facility found GMP violations.
UK firm expands on US launch of Nourished Vitamin Stacks gummies with protein bars made on a 3D printer and offering functional ingredients and more flavor options than most bars on the market, says CEO Melissa Snover.